JIP
MED icon

Jaffetilchin Investment Partners’s Medifast MED Stock Holding History

Jaffetilchin Investment Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-53
Closed -$1.01K – 903
2024
Q3 		$1.01K Buy
+53
New +$1.02K ﹤0.01% 1249

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jaffetilchin Investment Partners's MED Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Medifast (MED) in Q4 2024, closing a stake of 53 shares — an estimated $1.01K sold.

Jaffetilchin Investment Partners first reported a position in MED in Q3 2024 and held it in 1 quarter. The position peaked at $1.01K in Q3 2024. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 53 Medifast shares in Q4 2024, an estimated $1.01K.
  • Jaffetilchin Investment Partners first reported a position in Medifast in Q3 2024 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's Medifast position peaked at $1.01K in Q3 2024.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.